The bit that makes those results particularly significant is that concerning the collaboration with BioSkin GmbH, as announced on the 7th of November: " Bioskin is internationally recognised for their experience with the ‘psoriasis plaque test’ - which is clinically validated and utilised by a number of leading dermatology companies."
The last (drug to trial) could be the first (to partnership/licencing).
Bot Chart, page-120
-
- There are more pages in this discussion • 13,163 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.5¢ |
Change
0.015(4.17%) |
Mkt cap ! $590.6M | |||
| Open | High | Low | Value | Volume |
| 36.5¢ | 40.0¢ | 36.5¢ | $10.56M | 27.45M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 75348 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.5¢ | 514698 | 3 |
View Market Depth
| Last trade - 16.10pm 24/06/2024 (20 minute delay) ? |
| BOT (ASX) Chart |